An insider at Alnylam Pharmaceuticals bought $299,526 worth of shares recently.

Nov 12, 2026, 6:10 PM ETMarketRead the original at marketscreener.com

Neutral

Alnylam disclosed that an insider bought company shares worth $299,526. The filing reports no change to its medicines, sales, or results, so the company's outlook is unchanged.

ALNY · Alnylam Pharmaceuticals, Inc.

AI read · Neutral

The AI's read

A personal share purchase can signal confidence in the company. But this filing gives no new information about Alnylam's medicines, sales, or results. That leaves the company's outlook unchanged.

Get alerts for ALNY

Follow Alnylam Pharmaceuticals, Inc. (ALNY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ALNY

Free on the App Store and Google Play, or on the web.